Tech entrepreneurs and venture capitalists are applauding DeepSeek while cautioning that it reveals China is far more ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

"There's no real point in having regulation only in one region of the world, because AI sort of is across borders; it's going ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Business Insider's diary takes you behind the scenes on day three of the World Economic Forum in Davos.

In his new book, LinkedIn's Reid Hoffman argues that fear-focused responses to AI ignore the incredible promise this technological revolution holds.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big ...

Not many children dream of winning a Nobel Prize when they grow up, but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google ...